2004
DOI: 10.1016/j.ejphar.2004.06.052
|View full text |Cite
|
Sign up to set email alerts
|

Neuromuscular blocking agents block carotid body neuronal nicotinic acetylcholine receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
18
0
1

Year Published

2006
2006
2020
2020

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 35 publications
(23 citation statements)
references
References 27 publications
4
18
0
1
Order By: Relevance
“…Our main result of a specific depression of HVR but not HCVR with partial neuromuscular blockade is consistent with previous work and as previously shown [8,9,[35][36][37][38]…”
Section: Discussionsupporting
confidence: 93%
“…Our main result of a specific depression of HVR but not HCVR with partial neuromuscular blockade is consistent with previous work and as previously shown [8,9,[35][36][37][38]…”
Section: Discussionsupporting
confidence: 93%
“…In contrast, if the rabbit carotid body is stimulated with nicotine there is a distinct dose‐dependent increase in carotid sinus nerve discharge frequency (Jonsson et al . ). As for ATP, its Ca 2+ ‐dependent release in response to hypoxia in several animal models has been established, as well as the key role for P2X signalling through studies on knockout mice (Zhang et al .…”
Section: Discussionmentioning
confidence: 97%
“…Neuromuscular blocking agents, for example, vecuronium have been shown in humans to impair the HVR at concentrations where the patient's neuromuscular transmission is only slightly impaired and adequate enough to maintain protective airway reflexes, normal baseline ventilation, and ventilatory responses to hypercapnia (171)(172)(173). Subsequent in vitro experiments from the same institution using an isolated CB-sinus nerve preparation showed that neuromuscular blocking agents from different substance classes, that is, atracurium and vecuronium, impaired CB chemoreceptor activity through block of nACh receptors with an IC50 of 3.6 to 27 μM for atracurium and 1.6 to 7.3 μM for vecuronium depending on the nicotine concentration used to stimulate the CB nicotinic receptors (310). However, in humans the relevant ED90 plasma concentration for vecuronium that causes a 90% neuromuscular block has been reported to be 300 ng/mL (0.47 μM) (578) and the protein binding of vecuronium is reportedly 30% to 77% (153,183).…”
Section: Effects Of Neuromuscular Blocking Agents On the Peripheral Cmentioning
confidence: 97%